Project Review

Review Observed Facts And Committee Assumptions

Which project mix best advances BioQuarter's imaging and diagnostic translation goals inside a constrained committee round? Select a row and inspect the three-layer split: observed facts, committee assumptions, and calculated outputs.

How To Use This Page

Use the project drawer on the right as the canonical interpretation layer.

1. Start With Facts

Treat public stage, public funding facts, evidence summary, and source references as the observed layer.

2. Then Review Assumptions

Requested budgets, screening passes, rubric scores, and milestone costs are committee modelling inputs used to run the simulator consistently.

3. Read Outputs Last

Quality, milestone, cost-effectiveness, need, frontier, and scenario allocations are calculated outputs derived from the formula layer.

Observed facts should never be confused with round-sized budget assumptions.
All real rows remain explicitly marked as public-fact-backed cases.
Synthetic rows exist only to make the committee simulator more stress-testable.
Hybrid allocation on this page uses the DEAP 40/35/25 weight formula plus optimal-budget caps.

Portfolio Review Grid

Select a project row to inspect observed facts, committee assumptions, and calculated outputs.

ProjectHubTypePublic StageRequestedMin ViableOptimalQualityHybrid Allocation

CALCIVIS Imaging System

RB1

Edinburgh BioQuarterRealcommercial launch / US expansion£85,000£50,000£80,0007.25£59,254

Edinburgh Molecular Imaging cancer detection agents

RB2

Edinburgh BioQuarterRealclinical phase / Phase IIb£95,000£60,000£90,0006.05£44,241

NeuroLens

P1

Edinburgh BioQuarterSyntheticprototype£90,000£55,000£80,0007.35£66,327

SynthBioForge

P3

Edinburgh BioQuarterSyntheticearly research£120,000£70,000£100,0006.30£50,178

CALCIVIS Imaging System

RB1 · Edinburgh BioQuarter

Observed Facts

Public stage

commercial launch / US expansion

Evidence summary

BioQuarter describes CALCIVIS as a preventive-dentistry imaging company using a photoprotein to detect free calcium ions, and reports FDA PMA approval plus a later GBP 5 million raise for US rollout.

Public funding fact

£5,000,000

Source references

  • Edinburgh BioQuarter company profile: CALCIVIS
  • Edinburgh BioQuarter funding update: CALCIVIS

Committee Assumptions

Budget assumptions

Requested £85,000

Min viable £50,000

Optimal £80,000

Screening checks

Mandate Pass

Team Pass

Complete Pass

Budget Pass

Milestone Pass

Compliance Pass

Criterion scores

Strategic fit 9/10

Team 7/10

Feasibility 8/10

Market 7/10

Evidence 8/10

Milestone readiness 7/10

Capital efficiency 7/10

Frontier potential 7/10

Risk penalty 4/10

Milestone assumptions

US commercial rollout of imaging system

Cost £50,000 · Importance 8/10

Readiness 7/10 · Confidence 7/10 · Unlock value 8/10

Calculated Outputs

Quality score

7.25

Milestone score

7.55

Cost-effectiveness

0.151

Need score

22,050

Frontier score

7.70

Hybrid allocation

£59,254

Weight 26.9%